CrossRef Effects of caffeoylquinic acid analogs derived from aerial parts of Artemisia iwayomogi on adipogenesis Su-Young Han, Jisu Kim, Bo Kyeong Kim, Wan Kyunn Whang, Hyeyoung Min Food Science and Biotechnology.2023
France Research professionals have demonstrated that DSIP interacts with the central nervous system, and promotes sleep by modulating the activity of key neurotransmitters like gamma-aminobutyric acid (GABA) and serotonin, both crucial in initiating and maintaining restful sleep
This is also true of injectables, creams, and pills
Nicholls DG
No, GLP-1 receptor agonists are not FDA-approved for lipedema treatment
In January 2025 , Novo Nordisk announced expanded manufacturing capacity for GLP-1 therapies, increasing output by approximately 40% across its global facilities to address rising demand for semaglutide-based obesity and diabetes treatments